These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25099252)

  • 1. De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females.
    Popp B; Støve SI; Endele S; Myklebust LM; Hoyer J; Sticht H; Azzarello-Burri S; Rauch A; Arnesen T; Reis A
    Eur J Hum Genet; 2015 May; 23(5):602-9. PubMed ID: 25099252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
    McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
    BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.
    Bader I; McTiernan N; Darbakk C; Boltshauser E; Ree R; Ebner S; Mayr JA; Arnesen T
    BMC Med Genet; 2020 Jul; 21(1):153. PubMed ID: 32698785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.
    Saunier C; Støve SI; Popp B; Gérard B; Blenski M; AhMew N; de Bie C; Goldenberg P; Isidor B; Keren B; Leheup B; Lampert L; Mignot C; Tezcan K; Mancini GM; Nava C; Wasserstein M; Bruel AL; Thevenon J; Masurel A; Duffourd Y; Kuentz P; Huet F; Rivière JB; van Slegtenhorst M; Faivre L; Piton A; Reis A; Arnesen T; Thauvin-Robinet C; Zweier C
    Hum Mutat; 2016 Aug; 37(8):755-64. PubMed ID: 27094817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
    Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
    BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Manifestations in a Girl with NAA10-Related Syndrome and Genotype-Phenotype Correlation in Females.
    Maini I; Caraffi SG; Peluso F; Valeri L; Nicoli D; Laurie S; Baldo C; Zuffardi O; Garavelli L
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
    Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
    Hum Mol Genet; 2019 Sep; 28(17):2900-2919. PubMed ID: 31127942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
    Casey JP; Støve SI; McGorrian C; Galvin J; Blenski M; Dunne A; Ennis S; Brett F; King MD; Arnesen T; Lynch SA
    Sci Rep; 2015 Nov; 5():16022. PubMed ID: 26522270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.
    McTiernan N; Gill H; Prada CE; Pachajoa H; Lores J; ; Arnesen T
    Eur J Hum Genet; 2021 Feb; 29(2):280-288. PubMed ID: 32973342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.
    Støve SI; Blenski M; Stray-Pedersen A; Wierenga KJ; Jhangiani SN; Akdemir ZC; Crawford D; McTiernan N; Myklebust LM; Purcarin G; McNall-Knapp R; Wadley A; Belmont JW; Kim JJ; Lupski JR; Arnesen T
    Eur J Hum Genet; 2018 Sep; 26(9):1294-1305. PubMed ID: 29748569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of Ogden syndrome as an X-linked recessive fatal disorder due to a recurrent NAA10 variant and review of the literature.
    Gogoll L; Steindl K; Joset P; Zweier M; Baumer A; Gerth-Kahlert C; Tutschek B; Rauch A
    Am J Med Genet A; 2021 Aug; 185(8):2546-2560. PubMed ID: 34075687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAA10-related syndrome.
    Wu Y; Lyon GJ
    Exp Mol Med; 2018 Jul; 50(7):1-10. PubMed ID: 30054457
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    McTiernan N; Darbakk C; Ree R; Arnesen T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation.
    McTiernan N; Tranebjærg L; Bjørheim AS; Hogue JS; Wilson WG; Schmidt B; Boerrigter MM; Nybo ML; Smeland MF; Tümer Z; Arnesen T
    Hum Genet; 2022 Aug; 141(8):1355-1369. PubMed ID: 35039925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.
    Van Damme P; Støve SI; Glomnes N; Gevaert K; Arnesen T
    Mol Cell Proteomics; 2014 Aug; 13(8):2031-41. PubMed ID: 24408909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAA10 variant in 38-week-gestation male patient: a case study.
    Afrin A; Prokop JW; Underwood A; Uhl KL; VanSickle EA; Baruwal R; Wajda M; Rajasekaran S; Bupp C
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33335012
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Johnston JJ; Williamson KA; Chou CM; Sapp JC; Ansari M; Chapman HM; Cooper DN; Dabir T; Dudley JN; Holt RJ; Ragge NK; Schäffer AA; Sen SK; Slavotinek AM; FitzPatrick DR; Glaser TM; Stewart F; Black GC; Biesecker LG
    J Med Genet; 2019 Jul; 56(7):444-452. PubMed ID: 30842225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Manifestations Associated With the N-Terminal-Acetyltransferase NAA10 Gene Mutation in a Girl: Ogden Syndrome.
    Sidhu M; Brady L; Tarnopolsky M; Ronen GM
    Pediatr Neurol; 2017 Nov; 76():82-85. PubMed ID: 28967461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.